Apoptosis as a mechanism of cell death in liver allograft rejection

Transplantation

Volumn 59, Issue 4, 1995, Pages 621-625

  Krams, Sheri M ^a   Egawa, Hiroto ^a   Quinn, Maire B ^a   Villanueva, Janeth C ^a   Garcia Kennedy, Richard ^a   Martinez, Olivia M ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; LIVER ENZYME; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DNA DEGRADATION; GRAFT REJECTION; ISOGRAFT; LIVER FUNCTION; LIVER NECROSIS; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; APOPTOSIS; DNA DAMAGE; GRAFT REJECTION; LIVER; LIVER TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0028950199     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199559040-00031     Document Type: Article

References (29)

1. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251.
2. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is asso ciated with endogenous endonuclease activation. Nature 1980; 284: 555.
3. Williams GT. Programmed cell death: apoptosis and oncogene sis. Cell 1991; 65: 1097.
4. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597.
5. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 777.
6. Martinez OM, Krams SM (manuscript submitted).
7. Tien Q, Streuli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induce DNA fragmentation in target cells. Cell 1991; 67: 629.
8. Ando K, Guidotti LG, Wirth S, et al. Class I-restricted T lym phocytes are directly cytopathic for their targets in υiυo. J Immunol 1994; 152: 3245.
9. Fukuda K, Kojiro M, Chiu J-F. Induction of apoptosis by trans forming growth factor-βl in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology 1993; 18: 945.
10. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apop tosis in cultured hepatocytes and in regressing liver by transforming growth factor βl. Proc Natl Acad Sci USA 1992; 89:5408.
11. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985; 133: 1042.
12. Kamada N, Davies HFFS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981; 292: 840.
13. Snover DC, Freese DK, Sharp HL, et al. Liver allograft rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987; 11: 1.
14. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1.
15. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Comelisse CJ, Hein Van Dierendonck J. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993; 41: 7.
16. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992; 53: 151.
17. Martinez OM, Krams SM, Stemeck M, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53: 449.
18. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 1993; 55: 1159.
19. Farges O, Morris PJ, Dallman MJ. Spontaneous acceptance of liver allografts in the rat: analysis of the immune response. Transplantation 1994; 57: 171.
20. Fausto N. Hepatocyte apoptosis: is transforming growth factor the kiss of death? Hepatology 1993; 18: 1536.
21. Zamegar R, Michalopolis G. Purification and biological charac terization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989; 49: 3314.
22. McMahon JB, Richards WL, del Campo AA, Song M-KH, Thorgeirsson SS. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 1986; 46: 4665.
23. Fausto N, Webber EM. Control of liver growth. Crit Rev Eukaryot Gene Expr 1993; 3: 117.
24. Egawa H, Martinez GM, Quinn MB, et al. Acute liver allograft rejection in the rat: An analysis of the immune response. Transplantation 1995; 59.
25. Cohen JJ, Duke RC. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10: 267.
26. Dienes HP, Popper H, Arnold W, Loback H. Histologic observations in human hepatitis non A, non B. Hepatology 1982; 2: 256.
27. Kerr JF, Cooksley WG, Searle J, et al. The nature of piecemeal necrosis in chronic active hepatitis. Lancet 1979; 2: 827.
28. Oitval ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in υiυo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609.
29. Lipman ML, Stevens AC, Bleackley RC, et al. The strong corre lation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53: 73.